Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06968975 · ClinicalTrials.gov registry record
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
A clinical trial of Polyneuropathy, Inflammatory Demyelinating, Chronic, sponsored by Sanofi.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06968975: Recruiting study of Polyneuropathy, Inflammatory Demyelinating, Chronic, sponsored by Sanofi.
NCT06968975 is a study of Polyneuropathy, Inflammatory Demyelinating, Chronic that is actively recruiting participants, run by Sanofi. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06968975, a study of Polyneuropathy, Inflammatory Demyelinating, Chronic, is actively recruiting participants, sponsored by Sanofi.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three months of treatment with standard of care therapy. The study is expected to last two years. Enrollment is expected to continue for one year. Depending on when the participant is enrolled, a participant can be followed for between one and two years, through the end of study, approximately two years after the study starts.
Primary Outcome
The inflammatory Rasch-built overall disability scale (I-RODS) is a 24-item patient-reported questionnaire that captures disease impact on daily tasks with a score ranging from 0 (maximum disability) to 48 (no disability). It contains 24 items across an activity domain and a social participation domain. Each item is rated as "0": Not possible to perform; "1": possible, but with some difficulty, or "2" possible, without any difficulty.
Conditions Studied
Study Locations (1)
Pennsylvania
- Investigational Site - Swiftwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2027-05-17 |
What NCT06968975 shows while recruiting
NCT06968975 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Polyneuropathy, Inflammatory Demyelinating, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT06968975 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06968975 about?
NCT06968975 is a clinical study titled "Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)". This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three mont...
What is the current status of trial NCT06968975?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-04-11. Estimated completion is 2027-05-17.
What conditions does trial NCT06968975 study?
This clinical trial studies the following conditions: Polyneuropathy, Inflammatory Demyelinating, Chronic.
Who is sponsoring clinical trial NCT06968975?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06968975 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polyneuropathy, Inflammatory Demyelinating, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI